Persistence of UL‐VWF in the circulation leads to microvascular thrombosis and the highly morbid and potentially life threatening clinical manifestations observed in a host of infectious and non‐infectious diseases, such as sepsis and thrombotic thrombocytopenic purpura (TTP).4, 5. This evidence concerns the gene VWF and thrombotic thrombocytopenic purpura.